41 results on '"Terryn, Wim"'
Search Results
2. Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)
3. Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
4. IRF2BPL Is Associated with Neurological Phenotypes
5. An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease
6. Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with Covid-19: an open-label randomized controlled trial
7. Additional file 2 of Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
8. Additional file 2 of Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)
9. Additional file 6 of Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
10. Additional file 1 of Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
11. Additional file 5 of Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
12. Additional file 4 of Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
13. Additional file 7 of Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
14. Additional file 1 of Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)
15. Additional file 3 of Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
16. Mutations in RNU7-1 Weaken Secondary RNA Structure, Induce MCP-1 and CXCL10 in CSF, and Result in Aicardi-Goutières Syndrome with Severe End-Organ Involvement.
17. Screening for Fabry Disease in Male Patients With Arrhythmia Requiring a Pacemaker or an Implantable Cardioverter–Defibrillator
18. Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice
19. Chronic intestinal pseudo-obstruction due to β2microglobulin-amyloidosis in a patient on high-flux haemodialysis
20. Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipients
21. Two-tier approach for the detection of alpha-galactosidase A deficiency in a predominantly female haemodialysis population
22. Goodpastureʼs syndrome associated with autoimmune thrombotic thrombocytopenic purpura—an unusual case
23. A dramatic case of calciphylaxis 20 years after kidney transplantation
24. Future perspectives of genome-scale sequencing
25. SP777TAILORED IMMUNOSUPPRESSION IN DE NOVO RENAL TRANSPLANTATION BASED ON IMMUNE FUNCTION MONITORING: A RANDOMISED CONTROLLED TRIAL
26. Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
27. Aggressive extensive cardiac mass in an HIV-1-infected patient: should we go for comfort therapy?
28. Screening for Fabry disease: indications, methods and implications
29. Gouty Arthritis of the Spine in a Renal Transplant Patient
30. Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
31. Late onset ornithine transcarbamylase deficiency in a 61 year old male
32. Chronic kidney disease and an uncertain diagnosis of Fabry disease: Approach to a correct diagnosis
33. Consensus recommendation on Fabry disease diagnosis in adult patients with kidney disease
34. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy
35. Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice
36. Phenytoin intoxication in critically ill patients
37. Delayed graft function in renal transplantation
38. Aggressive extensive cardiac mass in an HIV-1-infected patient: should we go for comfort therapy?
39. Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice
40. Intermediate uveitis in common variable immunodeficiency (CVID) associated with a heterozygous variant in the TNFRSF13B gene.
41. Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.